Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Challenges to Lifestyle Medicine for Type 2 Diabetes in Iran: A Synoptic Review Publisher



Dehghani Firouzabadi M1 ; Sheikhy A1 ; Poopak A1 ; Esteghamati A1 ; Mechanick JI2 ; Dehghani Firouzabadi F1, 3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Kravis Center for Clinical Cardiovascular Health at Mount Sinai Heart and the Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, NY, United States
  3. 3. Department of Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, MD, United States

Source: American Journal of Lifestyle Medicine Published:2023


Abstract

Type 2 diabetes (T2D) is a major public health issue in Iran. The principal context for T2D management is the prevention of cardiovascular disease development and progression. These preventive strategies can be enhanced with routine implementation of comprehensive lifestyle modification, guideline-directed medical therapies, and creation of infrastructure that considers social determinants of health, ethnocultural variables, and financial challenges. In this synoptic review, scientific evidence sourced from Iran is analyzed to identify tactics to optimize the lifestyle medicine component of T2D care in Iran. Important evidence-based factors gleaned from the literature were curated into 9 categories: self-care, dietary adherence, mental health, self-comparison, transcultural adaptation, family support and community engagement, physical activity, the global pandemic, and service delivery. These categories were then assigned to 1 of 4 a priori aspects challenging diabetes care in Iran: behavioral factors, belief system, drivers, and implementation. By codifying discussion points and individual tactics, the improvement and optimization of T2D care in Iran can be facilitated. This reductionist model of approaching lifestyle medicine and complex chronic disease such as T2D can be applied to other ethnocultural populations. © Copyright 2023 The Author(s).
Related Docs
View other Related Docs
1. Challenges to Lifestyle Medicine for Type 2 Diabetes in Iran: A Synoptic Review, American Journal of Lifestyle Medicine (2025)
2. Non-Communicable Diseases’ Risk Factors in Iran; a Review of the Present Status and Action Plans, Journal of Diabetes and Metabolic Disorders (2021)
3. Quality of Care in Type 2 Diabetes in Iran; a Cross-Sectional Study Using Patient-Level Data, BMC Endocrine Disorders (2022)
4. Evaluation of the Diabetes Care Cascade and Compliance With Who Global Coverage Targets in Iran Based on Steps Survey 2021, Scientific Reports (2023)
5. Identifying Associations Between Health Services Operational Factors and Health Experience for Patients With Type 2 Diabetes in Iran, BMC Health Services Research (2021)
6. Trends in Cardiovascular Risk Factors in Diabetic Patients in Comparison to General Population in Iran: Findings From National Surveys 2007–2016, Scientific Reports (2020)
7. Diabetes Care in Iran: Where We Stand and Where We Are Headed, Annals of Global Health (2015)
8. Reasons for Non-Participation in a Self-Care Training Program for Diabetic Patients: A Qualitative Study, BMC Health Services Research (2022)
Experts (# of related papers)
View all Related Experts
Bagher Larijani (23)
Alireza Esteghamati (14)
Other Related Docs
9. The Diabetes Cascade of Care Through the 14 Years in Iran: Findings of Nationwide Steps Surveys 2007–2021, Journal of Diabetes and Metabolic Disorders (2023)
10. Management Goal Achievements of Diabetes Care in Iran: Study Profile and Main Findings of Diacare Survey, Journal of Diabetes and Metabolic Disorders (2023)
11. Prevalence of Diabetes and Prediabetes, and Achievements in Diabetes Control in Iran; the Results of the Steps of 2016, Archives of Iranian Medicine (2022)
12. Health Indicators in the Management of Diabetes in Primary Health Care: Iran-Package of Essential Non-Communicable Diseases (Irapen) Program, Journal of Diabetes and Metabolic Disorders (2025)
13. Determinants of Glycemic Control: Phase 2 Analysis From Nationwide Diabetes Report of National Program for Prevention and Control of Diabetes (Nppcd-2018), Primary Care Diabetes (2020)
14. Prevalence and Determinants of Diabetes and Prediabetes in Southwestern Iran: The Khuzestan Comprehensive Health Study (Kchs), BMC Endocrine Disorders (2021)
15. National and Subnational Survey on Diabetes Burden and Quality of Care Index in Iran: A Systematic Analysis of the Global Burden of Disease Study 1990–2019, Journal of Diabetes and Metabolic Disorders (2022)
16. Knowledge Gaps in Diabetes Research: An Evidence Mapping of the Literature, Journal of Diabetes and Metabolic Disorders (2022)
17. Quality and Cost of Healthcare Services in Patients With Diabetes in Iran: Results of a Nationwide Short-Term Longitudinal Survey, Frontiers in Endocrinology (2023)
18. Prevalence, Awareness, Treatment and Control of Diabetes Among Iranian Population: Results of Four National Cross-Sectional Stepwise Approach to Surveillance Surveys, BMC Public Health (2022)
19. Diabetes in Iran: Prospective Analysis From First Nationwide Diabetes Report of National Program for Prevention and Control of Diabetes (Nppcd-2016), Scientific Reports (2017)
20. Evaluation of the Effectiveness of Persian Diabetes Self-Management Education in Older Adults With Type 2 Diabetes at a Diabetes Outpatient Clinic in Tehran: A Pilot Randomized Control Trial, Journal of Diabetes and Metabolic Disorders (2020)
21. Pharmacoeconomic Evaluation of Insulin Aspart and Glargine in Type 1 and 2 Diabetes Mellitus in Iran, Journal of Diabetes and Metabolic Disorders (2023)
22. Modeling Computerized Physician Order Entry With Decision Support System for Diabetic Patients, Frontiers in Health Informatics (2020)
23. Cardiovascular Events in People With Type 2 Diabetes: Performance of Framingham, Ukpds, and Advance Risk Equations, Acta Medica Iranica (2021)
24. Burden of Type 1 Diabetes Mellitus in the North Africa and Middle East Region, 1990–2019; Findings From the Global Burden of Disease Study, Diabetes Research and Clinical Practice (2022)
25. Inequalities in the Prevalence, Diagnosis Awareness, Treatment Coverage and Effective Control of Diabetes: A Small Area Estimation Analysis in Iran, BMC Endocrine Disorders (2023)
26. Evaluation of Diabetes Care Parameters in Patients With Diabetes: A Population-Based Cross-Sectional Study in Khuzestan Province (Southwest of Iran), Journal of Diabetes and Metabolic Disorders (2024)
27. The Impact of Personality Traits on Medication Adherence and Self-Care in Patients With Type 2 Diabetes Mellitus: The Moderating Role of Gender and Age, Journal of Psychosomatic Research (2020)
28. Neutrophil Gelatinase-Associated Lipocalin and Retinol-Binding Protein-4 As Biomarkers for Diabetic Kidney Disease, Kidney and Blood Pressure Research (2020)
29. Iran Diabetes Research Study; Knowledge Discovery in Diagnosis: A Scoping Review, Journal of Diabetes and Metabolic Disorders (2021)
30. Estimating the Attributable Risk of Vascular Disorders in Different Ranges of Fasting Plasma Glucose and Assessing the Effectiveness of Anti-Diabetes Agents on Risk Reduction; Questioning the Current Diagnostic Criteria, Journal of Diabetes and Metabolic Disorders (2020)
31. Prevalence and Trends of Coronary Artery Disease Risk Factors and Their Effect on Age of Diagnosis in Patients With Established Coronary Artery Disease: Tehran Heart Center (2005–2015), BMC Cardiovascular Disorders (2021)
32. Six-Month Follow-Up of Covid-19 Patients: Mortality and Related Factors, Archives of Iranian Medicine (2022)
33. Impact of Gender on Chronic Complications in Participants With Type 2 Diabetes: Evidence From a Cross-Sectional Study, Endocrinology# Diabetes and Metabolism (2024)
34. Levels and Trends of Bmi, Obesity, and Overweight at National and Sub-National Levels in Iran From 1990 to 2016; a Comprehensive Pooled Analysis of Half a Million Individuals, Archives of Iranian Medicine (2021)
35. Diabetic Foot Self-Care Practice in Women With Diabetes in Iran, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2021)
36. Endocrinology and Metabolism Research Institute From Inception to Maturity: An Overview of 25-Year Activity, Journal of Diabetes and Metabolic Disorders (2020)
37. Cardiometabolic Risk Factors Trend in Iranian Adults With Hypertension Over 15 Years: Findings of Nationwide Steps of 2007–2021, Journal of Diabetes and Metabolic Disorders (2024)
38. Classification of the Present Pharmaceutical Agents Based on the Possible Effective Mechanism on the Covid-19 Infection, DARU# Journal of Pharmaceutical Sciences (2020)
39. Long-Term Cost-Effectiveness of Quality of Diabetes Care; Experiences From Private and Public Diabetes Centers in Iran, Health Economics Review (2022)
40. Estimation of Myocardial Infarction Death in Iran: Artificial Neural Network, BMC Cardiovascular Disorders (2022)
41. Assessment of Hemoglobin A1c Management and Prescription Cost Due to Polypharmacy Among Patients With Diabetes in Iran Based on the Steps Iran 2016 Survey and a Prescription Database: A Multi-Level, Cross-Sectional National Study, Archives of Iranian Medicine (2024)
42. Despite Affordability, Low Utilization of Lipid Lowering Drugs in Iran: Trend Analysis and Benchmarking 2005-2016, Iranian Journal of Pharmaceutical Research (2019)
43. Epidemiology of Adult Diabetes Mellitus and Its Correlates in Pars Cohort Study in Southern Iran, Archives of Iranian Medicine (2019)
44. Mapping Evidence of Iran Diabetes Research: Protocol for a Scoping Review, Journal of Diabetes and Metabolic Disorders (2022)
45. Importance of Population-Wide Studies in Controlling Noncommunicable Diseases: Achievements of Non-Communicable Diseases Research Center, Endocrinology and Metabolism Research Institute, Iranian Journal of Diabetes and Metabolism (2021)
46. Ottawa Charter Framework As a Guide for Type 2 Diabetes Prevention and Control in Iran, Journal of Diabetes and Metabolic Disorders (2019)
47. High Prevalence of Comorbidities in Older Adult Patients With Type 2 Diabetes: A Cross-Sectional Survey, BMC Geriatrics (2024)
48. Gabric Diabetes School: An Innovative Education Centre for People With Diabetes; [Gabric, L’Ecole Du Diabete: Un Centre D’Education Pour Diabetiques Innovant], Eastern Mediterranean Health Journal (2018)
49. Adherence to Medications, Self-Care Activity, and Hba1c Status Among Patients With Type 2 Diabetes Living in an Urban Area of Iran, Journal of Diabetes and Metabolic Disorders (2018)
50. Lipid Management Strategies for Diabetic Patients Align With an Evidence-Based Guideline, DARU, Journal of Pharmaceutical Sciences (2024)